A nonisotopic probe (Gen-Probe PACE; Gen-Probe, Inc., San Diego, Calif.) for detection of Chlamydia trachomatis in endocervical specimens was evaluated in 344 women attending a dysplasia clinic or an obstetrics clinic and 158 women who visited an emergency room. For each patient, the probe, a tissue cell culture, and a direct immunofluorescent-antibody test (DFA; MicroTrak; Syva Co., Palo Alto, Calif.) were used. C. trachomatis was detected in 54 specimens by at least one method. Forty-four, 44, and 37 specimens were positive by culture, probe, and DFA, respectively, and 31 were positive by all three methods. Considering culture-positive plus both probe-and DFA-positive results as the "gold standard," we determined the overall sensitivity, specificity, and positive and negative predictive values of the probe to be 80, 98, 82, and 98%, respectively. These values were 94, 98, 84, and 99%, respectively, in emergency room patients and 71, 98, 80, and 97%, respectively, in clinic patients. The sensitivities, specificities, and negative predictive values of the DFA and probe were comparable. The positive predictive values of the DFA in all patients and in emergency room and clinic patients were 97, 100, and 95%, respectively. Given the number of probe-positive results that were not confirmed by culture, we do not recommend using the Gen-Probe PACE to screen for C. trachomatis in women with a low to moderate risk for infection.
Chlamydia trachomatis is the most common cause of sexually transmitted disease in the United States today (3) . Tissue cell culture is considered the reference method for detection of C. trachomatis in clinical specimens. However, tissue culture requires a minimum incubation of 48 h and is costly. Antigen detection methods have made rapid and cost-effective screening for C. trachomatis possible. A direct immunofluorescent-antibody test (DFA) that uses monoclonal antibodies to the species-specific outer membrane protein was the first such test introduced. The sensitivity of the DFA in females has ranged from 70 to 100% and is dependent upon the type of patient population studied and the cutoff used for a positive result (2, 4, (6) (7) (8) (9) ). An enzyme immunoassay was developed shortly after the DFA. The sensitivity of the enzyme immunoassay in females has ranged from about 70 to 90%, depending on the patient population (1, 5, 10) . In general, the specificity and positive predictive value of the enzyme immunoassay have been lower than those of the DFA, especially in the low-risk group of women. Recently, a nonisotopic DNA probe for detection of C. trachomatis in genital specimens became commercially available (Gen-Probe PACE; Gen-Probe Inc., San Diego, Calif.). Between July 1988 and February 1989, we evaluated this probe assay in 158 women visiting the emergency room and in 344 women attending the dysplasia clinic or the obstetrics clinic at the University of Nebraska Medical Center. In addition to the probe, single-passage tissue cell culture (13) and the DFA, which has been the method routinely used to screen for C. trachomatis at this institution for the past 3 years, were also used.
Specimen collection. Three endocervical samples were collected after the exocervix was cleaned. All house staff in the two departments participated in the study. The order of specimen collection was rotated as follows: DFA, probe, * Corresponding author. and culture for the first 174; probe, culture, and DFA for the second 172; and culture, DFA, and probe for the remainder. For collection and preparation of the DFA specimens, we used the MicroTrak collection kit (Syva Co., Palo Alto, Calif.). The specimens were air dried, fixed with methanol, and refrigerated until stained (within 24 h of receipt). For the probe assay, the Gen-Probe PACE collection kit was used. Samples were stored at room temperature for up to 1 week prior to being tested. For culture, samples were collected with a calcium alginate swab and placed in 1. There were 18 discrepancies between the culture and probe results. Nine were culture positive and probe negative. Four of these were also positive by the DFA. Culture yielded less than or equal to five inclusions on one or both cover slips for three of the nine; however, culture yielded a similar number of inclusions for three specimens positive by all methods. The probe result for two of these nine specimens was within 200 relative light units of the positive cutoff value; two culture-negative specimens also yielded probe results in this range. The probe sample was collected first, second, and third from three, four, and two, respectively, of the nine patients. Of the nine probe-positive, culture-nega- tive specimens, one was positive by the DFA and one yielded inconclusive DFA results. The probe sample was collected first, second, and third from five, zero, and four, respectively, of the nine patients. Eleven patients had discrepant culture and DFA results. Nine were culture positive and DFA negative. Culture yielded less than or equal to five inclusions on both cover slips for two of these. The DFA sample was collected first, second, and third from three, three, and three, respectively, of these nine patients. Both of the two DFA-positive, culture-negative specimens were collected third.
The sensitivities, specificities, and positive and negative predictive values of the probe and DFA were calculated by using as the "gold standard" the number of specimens positive by culture and by both the probe and the DFA. The reliability of each method in clinic patients, emergency room patients, and all patients is shown in Table 1 . The sensitivities of the probe and DFA were identical in all patient groups (71% in clinic patients, 94% in emergency room patients, and 80% overall). The negative predictive values of both tests were comparable. The probe had a specificity of 98% in all patients groups, and the specificity of the DFA approached 100%. The positive predictive value of the probe (80 to 84%) was lower than that of the DFA (95 to 97%) in all patient groups. Culture had a sensitivity of 98%.
Six of the 10 patients with negative culture and positive probe and/or DFA results were symptomatic, as determined by chart review. Two had physical findings (i.e., mucopurulent cervical discharge, pain on motion of the cervix) highly suggestive of a C. trachomatis infection, and both were treated as outpatients with doxycycline. The remaining four presented with right-lower-quadrant pain. One had candida vaginitis, one was diagnosed with periappendiceal fibrosis by exploratory laparotomy, one had a urinary tract infection, and one was released from the emergency room without a specific gynecologic diagnosis. Of the four asymptomatic patients, three were attending the dysplasia clinic for colposcopy and biopsy following Pap smear-diagnosed dysplasia, and one was attending the obstetrics clinic for a routine prenatal examination.
Problems with the probe assay of low sensitivity and false-positive results identified in As with any evaluation of a test for detection of C. trachomatis, there were inherent problems in our study design. First, when multiple samples are collected from one site, the possibility exists that the order of collection will bias the results. Therefore, the order of sample collection was rotated. The order of collection did not appear to have a major influence on results. Specimen randomization was further enhanced by the fact that a large number of clinicians, each collecting the specimen with different vigor, were involved in the evaluation. Second, and most importantly, the sensitivity of culture, which is the gold standard against which new tests are compared, is less than 100% (6, 11, 12) . Consequently, interpretation of positive probe results that were not confirmed by culture was difficult. One possible explanation for these results is that we failed to detect all positive specimens by culture since we did not perform blind passage; however, in our experience blind passage has not significantly increased the detection of positive specimens. Likewise, others have failed to demonstrate increased detection by performing blind passage (13) . Another possible reason for probe-positive, culture-negative results is that the probe was hybridizing to an unidentified substance in the specimen. Charts were reviewed to discern the likelihood of C. trachomatis infection. However, because many patients infected with C. trachomatis are asymptomatic, this approach does not adequately address the discrepant test results. A final criticism involves the relatively small sample size. Although we were unable to document a significant difference between tissue cell culture and probe results, the number of tests that were positive by the probe but not confirmed by culture is disconcerting and should be used as preliminary data to initiate a larger study.
In summary, given the number of probe-positive, culturenegative samples, we cannot recommend using the PACE system to screen for C. trachomatis in women with a low to moderate risk for infection. Moreover, when the probe assay is used, it is not possible to assess the quality of the specimen, which is one advantage of the DFA. However, a modified Gen-Probe PACE assay, which requires less handson time, has been developed. We are presently evaluating this improved system, and we plan to perform a more in-depth evaluation of specimens yielding discrepant results.
